Fenocor 67mg Capsule contains Fenofibrate, a lipid-modifying agent used primarily to treat high cholesterol and triglyceride levels in the blood. Fenofibrate works by activating peroxisome proliferator-activated receptors (PPARs), which play a key role in regulating lipid metabolism. This action helps reduce low-density lipoprotein (LDL) cholesterol and triglycerides while increasing high-density lipoprotein (HDL) cholesterol, thereby improving overall lipid profiles. Fenocor is typically prescribed for patients with hyperlipidemia or mixed dyslipidemia who have not achieved adequate lipid control through diet and lifestyle changes alone. It is also beneficial in reducing the risk of cardiovascular events associated with elevated lipid levels. The 67mg dosage is designed for once-daily administration, providing effective lipid control with convenient dosing. Patients should take Fenocor with food to enhance absorption and minimize gastrointestinal discomfort. Common side effects may include gastrointestinal symptoms such as nausea, abdominal pain, or diarrhea, and less frequently, muscle pain or liver enzyme alterations. Regular monitoring of liver function and lipid levels is recommended during therapy. Fenocor should be used cautiously in patients with pre-existing liver or kidney conditions and is contraindicated in those with gallbladder disease or hypersensitivity to fenofibrate. Always consult a healthcare professional before starting or discontinuing this medication.